{"disease":{"id":"hyperlipidemia-and-mixed-dyslipidemia","name":"hyperlipidemia and mixed dyslipidemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01854918","title":"Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3681,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT02189837","title":"Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Amgen","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}